盐酸美沙酮片剂用于慢性癌症疼痛治疗中国专家共识解读  

Interpretation of Chinese experts'consensus on clinical application of methadone in cancer pain

作　　者：龚黎燕 金毅 GONG Liyan;JIN Yi(Department of Pain&Rehabilitation Medicine,The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Institute of Basic Medicine and Cancer(IBMC),Chinese Academy of Sciences,Hangzhou 310022,China;Department of Pain Medicine,Affiliated Jinling Hospital,Medical School of Nanjing University,Nanjing 221004,China)

机构地区：[1]中国科学院大学附属肿瘤医院(浙江省肿瘤医院)疼痛康复科,中国科学院基础医学与肿瘤研究所,杭州310022 [2]南京大学医学院附属金陵医院疼痛科,南京221004

出　　处：《中国疼痛医学杂志》2023年第4期244-248,共5页Chinese Journal of Pain Medicine

基　　金：浙江省医药卫生科技项目(2018KY312);浙江省自然科学基金项目(LY19H290001)。

摘　　要：美沙酮是世界卫生组织(WHO)癌痛三阶梯治疗中的第三阶梯强阿片药物,具有独特的镇痛效果,但在国内相关领域美沙酮并未得到充分应用。为了指导美沙酮在中国慢性癌痛病人中的临床应用,中国麻醉药品协会组织国内相关领域专家撰写盐酸美沙酮片剂用于慢性癌症疼痛治疗中国专家共识(简称《共识》)。本文对《共识》中的重点内容进行解读,旨在加深医护人员对《共识》的认识,促进美沙酮规范应用于慢性癌痛的镇痛治疗。Methadone is a synthetic opioid with unique characteristics utilized in the treatment of cancer pain,which incorporated in WHO ladder as step 3 opioid but lack of experience in China currently.In order to guide the clinical application of methadone in patients with cancer pain,experts from China National Narcotic Drugs Association has reached a consensus.This article aimed to interpret the key points of this experts'consensus and guide clinical practice.

关 键 词：美沙酮 癌症疼痛 专家共识 解读 

分 类 号：R730.5[医药卫生—肿瘤]